A Colombian AI Startup Wants to Assist Half of Latin America’s Doctors. Andreessen Horowitz Just Backed It.

Why It Matters

The funding accelerates AI‑driven efficiency in a region plagued by doctor shortages and heavy administrative loads, potentially reshaping how Latin American clinicians deliver care.

Key Takeaways

• $33M Series A led by a16z lifts total funding to $42M
• Goal: assist 950,000 doctors (half of 1.9M) by 2027
• Doctors save average 1.7 hours daily using Telepatia
• Platform already reached 14M patients across 25+ institutions
• Plans to expand to India, Africa, Southeast Asia after Latin America

Pulse Analysis

Latin America faces a chronic shortage of physicians, with Brazil and Colombia lagging the OECD average by roughly a third. Administrative tasks consume up to 70 % of clinicians’ time, eroding patient‑facing care. Telepatia’s AI‑powered assistant tackles this bottleneck by transcribing consultations, cross‑checking records, and surfacing guideline‑based recommendations, effectively acting as a “second brain” for doctors. By automating documentation, the platform promises to free up valuable clinician hours, a critical advantage in markets where each doctor serves a larger patient pool.

The $33 million Series A from Andreessen Horowitz not only validates Telepatia’s technology but also signals growing investor confidence in AI‑enabled health solutions outside the United States. Early adoption metrics are compelling: physicians in Brazil log eight hours of usage per day and reclaim 1.7 hours of productive time, while the startup has already impacted 14 million patients through more than 25 health networks. Such traction demonstrates that AI can deliver measurable efficiency gains, making the business case attractive for hospitals seeking to stretch limited staff resources.

Regulatory frameworks in Brazil and Colombia are evolving, with AI‑specific bills poised for final approval. Telepatia’s cautious positioning—supporting clinicians without supplanting decision‑making—helps navigate these nascent rules. After consolidating its Latin American foothold, the company eyes expansion into India, Africa, and Southeast Asia, regions that share similar workforce constraints. Success there could cement Telepatia as a global player in AI‑driven clinical assistance, reinforcing the broader trend of technology reshaping healthcare delivery worldwide.